|
1
|
Adzic-Vukicevic T, Mladenovic M, Jovanovic
S, Soldatović I and Radovanovic-Spurnic A: Invasive fungal disease
in COVID-19 patients: A single-center prospective observational
study. Front Med (Lausanne). 10(1084666)2023.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Liu Q, Chen P, Xin L, Zhang J and Jiang M:
A rare intestinal mucormycosis caused by Lichtheimia ramosa in a
patient with diabetes: A case report. Front Med (Lausanne).
11(1435239)2024.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Mori G, Diotallevi S, Farina F, Lolatto R,
Galli L, Chiurlo M, Acerbis A, Xue E, Clerici D, Mastaglio S, et
al: High-Risk neutropenic fever and invasive fungal diseases in
patients with hematological malignancies. Microorganisms.
12(117)2024.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Sun Y, Huang H, Chen J, Li J, Ma J, Li J,
Liang Y, Wang J, Li Y, Yu K, et al: Invasive fungal infection in
patients receiving chemotherapy for hematological malignancy: A
multicenter, prospective, observational study in China. Tumour
Biol. 36:757–767. 2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Li C, Zhu DP, Chen J, Zhu XY, Li NN, Cao
WJ, Zhang ZM, Tan YH, Hu XX, Yuan HL, et al: Invasive fungal
disease in patients undergoing allogeneic hematopoietic stem cell
transplantation in China: A multicenter epidemiological study
(CAESAR 2.0). Clin Infect Dis. 80:807–816. 2025.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Schmiedel Y and Zimmerli S: Common
invasive fungal diseases: An overview of invasive candidiasis,
aspergillosis, cryptococcosis, and Pneumocystis pneumonia.
Swiss Med Wkly. 146(w14281)2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Richardson M and Lass-Flörl C: Changing
epidemiology of systemic fungal infections. Clin Microbiol Infect.
14 (Suppl 4):S5–S24. 2008.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Zabolinejad N, Naseri A, Davoudi Y, Joudi
M and Aelami MH: Colonic basidiobolomycosis in a child: Report of a
culture-proven case. Int J Infect Dis. 22:41–43. 2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Huppler AR, Fisher BT, Lehrnbecher T,
Walsh TJ and Steinbach WJ: Role of molecular biomarkers in the
diagnosis of invasive fungal diseases in children. J Pediatric
Infect Dis Soc. 6 (Suppl 1):S32–S44. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Fisher BT, Westling T, Boge CLK, Zaoutis
TE, Dvorak CC, Nieder M, Zerr DM, Wingard JR, Villaluna D,
Esbenshade AJ, et al: Prospective evaluation of galactomannan and
(1→3) β-d-glucan assays as diagnostic tools for invasive fungal
disease in children, adolescents, and young adults with acute
myeloid leukemia receiving fungal prophylaxis. J Pediatric Infect
Dis Soc. 10:864–871. 2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Huang J, Liu C and Zheng X: Clinical
features of invasive fungal disease in children with no underlying
disease. Sci Rep. 12(208)2022.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Lehrnbecher T, Hassler A, Groll AH and
Bochennek K: Diagnostic approaches for invasive
aspergillosis-specific considerations in the pediatric population.
Front Microbiol. 9(518)2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Zimmermann P, Brethon B, Roupret-Serzec J,
Caseris M, Goldwirt L, Baruchel A and de Tersant M: Isavuconazole
treatment for invasive fungal infections in pediatric patients.
Pharmaceuticals (Basel). 15(375)2022.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Rosen GP, Nielsen K, Glenn S, Abelson J,
Deville J and Moore TB: Invasive fungal infections in pediatric
oncology patients: 11-year experience at a single institution. J
Pediatr Hematol Oncol. 27:135–140. 2005.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Blauwkamp TA, Thair S, Rosen MJ, Blair L,
Lindner MS, Vilfan ID, Kawli T, Christians FC, Venkatasubrahmanyam
S, Wall GD, et al: Analytical and clinical validation of a
microbial cell-free DNA sequencing test for infectious disease. Nat
Microbiol. 4:663–674. 2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Schlaberg R, Chiu CY, Miller S, Procop GW
and Weinstock G: Professional Practice Committee and Committee on
Laboratory Practices of the American Society for Microbiology;
Microbiology Resource Committee of the College of American
Pathologists. Validation of metagenomic next-generation sequencing
tests for universal pathogen detection. Arch Pathol Lab Med.
141:776–786. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Agudelo-Pérez S, Fernández-Sarmiento J,
Rivera León D and Peláez RG: Metagenomics by next-generation
sequencing (mNGS) in the etiological characterization of neonatal
and pediatric sepsis: A systematic review. Front Pediatr.
11(1011723)2023.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Wilke J, Ramchandar N, Cannavino C, Pong
A, Tremoulet A, Padua LT, Harvey H, Foley J, Farnaes L and Coufal
NG: Clinical application of cell-free next-generation sequencing
for infectious diseases at a tertiary children's hospital. BMC
Infect Dis. 21(552)2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Hsu AJ, Hanisch BR, Fisher BT and Huppler
AR: Pipeline of novel antifungals for invasive fungal disease in
transplant recipients: A pediatric perspective. J Pediatric Infect
Dis Soc. 13 (Suppl 1):S68–S79. 2024.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Ávila Montiel D, Saucedo Campos A, Avilés
Robles M, Murillo Maldonado MA, Jiménez Juárez R, Silva Dirzo M and
Dorantes Acosta E: Fungal infections in pediatric patients with
acute myeloid leukemia in a tertiary hospital. Front Public Health.
11(1056489)2023.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Otto WR, Dvorak CC, Boge CLK,
Ostrosky-Zeichner L, Esbenshade AJ, Nieder ML, Alexander S,
Steinbach WJ, Dang H, Villaluna D, et al: Prospective evaluation of
the fungitell® (1→3) beta-D-glucan assay as a diagnostic
tool for invasive fungal disease in pediatric allogeneic
hematopoietic cell transplantation: A report from the children's
oncology group. Pediatr Transplant. 27(e14399)2023.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Olivier-Gougenheim L, Rama N, Dupont D,
Saultier P, Leverger G, AbouChahla W, Paillard C, Gandemer V,
Theron A, Freycon C, et al: Invasive fungal infections in
immunocompromised children: Novel insight following a national
study. J Pediatr. 236:204–210. 2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Fisher BT, Robinson PD, Lehrnbecher T,
Steinbach WJ, Zaoutis TE, Phillips B and Sung L: Risk factors for
invasive fungal disease in pediatric cancer and hematopoietic stem
cell transplantation: A systematic review. J Pediatric Infect Dis
Soc. 7:191–198. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Yeoh DK, Moore AS, Kotecha RS, Bartlett
AW, Ryan AL, Cann MP, McMullan BJ, Thursky K, Slavin M, Blyth CC,
et al: Invasive fungal disease in children with acute myeloid
leukaemia: An Australian multicentre 10-year review. Pediatr Blood
Cancer. 68(e29275)2021.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Mor M, Gilad G, Kornreich L, Fisher S,
Yaniv I and Levy I: Invasive fungal infections in pediatric
oncology. Pediatr Blood Cancer. 56:1092–1097. 2011.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Calle-Miguel L, Garrido-Colino C,
Santiago-García B, Moreno Santos MP, Gonzalo Pascual H, Ponce Salas
B, Beléndez Bieler C, Navarro Gómez M, Guinea Ortega J and
Rincón-López EM: Changes in the epidemiology of invasive fungal
disease in a Pediatric hematology and oncology unit: The relevance
of breakthrough infections. BMC Infect Dis. 23(348)2023.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Lin GL, Chang HH, Lu CY, Chen CM, Lu MY,
Lee PI, Jou ST, Yang YL, Huang LM and Chang LY: Clinical
characteristics and outcome of invasive fungal infections in
pediatric acute myeloid leukemia patients in a medical center in
Taiwan. J Microbiol Immunol Infect. 51:251–259. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Sezgin Evim M, Tüfekçi Ö, Baytan B, Ören
H, Çelebi S, Ener B, Üstün Elmas K, Yılmaz Ş, Erdem M,
Hacımustafaoğlu MK and Güneş AM: Invasive fungal infections in
children with leukemia: Clinical features and prognosis. Turk J
Haematol. 39:94–102. 2022.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Tüfekçi Ö, Yılmaz Bengoa Ş, Demir
Yenigürbüz F, Şimşek E, Karapınar TH, İrken G and Ören H:
Management of invasive fungal infections in pediatric acute
leukemia and the appropriate time for restarting chemotherapy. Turk
J Haematol. 32:329–337. 2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Lehrnbecher T, Groll AH, Cesaro S, Alten
J, Attarbaschi A, Barbaric D, Bodmer N, Conter V, Izraeli S, Mann
G, et al: Invasive fungal diseases impact on outcome of childhood
ALL-an analysis of the international trial AIEOP-BFM ALL 2009.
Leukemia. 37:72–78. 2023.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Donnelly JP, Chen SC, Kauffman CA,
Steinbach WJ, Baddley JW, Verweij PE, Clancy CJ, Wingard JR,
Lockhart SR, Groll AH, et al: Revision and update of the consensus
definitions of invasive fungal disease from the european
organization for research and treatment of cancer and the mycoses
study group education and research consortium. Clin Infect Dis.
71:1367–1376. 2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Jenks JD, Cornely OA, Chen SC, Thompson GR
III and Hoenigl M: Breakthrough invasive fungal infections: Who is
at risk? Mycoses. 63:1021–1032. 2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Liberatore C, Farina F, Greco R, Giglio F,
Clerici D, Oltolini C, Lupo Stanghellini MT, Barzaghi F, Vezzulli
P, Orsenigo E, et al: Breakthrough invasive fungal infections in
allogeneic hematopoietic stem cell transplantation. J Fungi
(Basel). 7(347)2021.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Cornely OA, Hoenigl M, Lass-Flörl C, Chen
SC, Kontoyiannis DP, Morrissey CO and Thompson GR III: Mycoses
Study Group Education and Research Consortium (MSG-ERC) and the
European Confederation of Medical Mycology (ECMM). Defining
breakthrough invasive fungal infection-position paper of the
mycoses study group education and research consortium and the
European confederation of medical mycology. Mycoses. 62:716–729.
2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Arendrup MC, Arikan-Akdagli S, Jørgensen
KM, Barac A, Steinmann J, Toscano C, Arsenijevic VA, Sartor A,
Lass-Flörl C, Hamprecht A, et al: European candidaemia is
characterised by notable differential epidemiology and
susceptibility pattern: Results from the ECMM Candida III
study. J Infect. 87:428–437. 2023.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Marín Martínez EM, Aller García AI and
Martín-Mazuelos E: Epidemiology, risk factors and in vitro
susceptibility in candidaemia due to non-Candida albicans
species. Rev Iberoam Micol. 33:248–252. 2016.(In Spanish).
|
|
37
|
Castagnola E, Mariani M, Ricci E, Russo C,
Saffioti C and Mesini A: Fungal infections in pediatric patients:
Challenges and considerations in treatment. Expert Rev Anti Infect
Ther: Oct 12, 2025 (Epub ahead of print).
|
|
38
|
Popova M and Rogacheva Y: Epidemiology of
invasive fungal diseases in patients with hematological
malignancies and haematopoietic cell transplantation recipients:
Systematic review and meta-analysis of trends over time. J Infect
Public Health. 18(102804)2025.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Lehrnbecher T: The clinical management of
invasive mold infection in children with cancer or undergoing
hematopoietic stem cell transplantation. Expert Rev Anti Infect
Ther. 17:489–499. 2019.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Groll AH, Pana D, Lanternier F, Mesini A,
Ammann RA, Averbuch D, Castagnola E, Cesaro S, Engelhard D,
Garcia-Vidal C, et al: 8th European conference on infections in
leukaemia: 2020 Guidelines for the diagnosis, prevention, and
treatment of invasive fungal diseases in paediatric patients with
cancer or post-haematopoietic cell transplantation. Lancet Oncol.
22:e254–e269. 2021.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Wang Q, Lei Y, Wang J, Xu X, Wang L, Zhou
H and Guo Z: Tumor and microecology committee of China anti-cancer
association. Expert consensus on the relevance of intestinal
microecology and hematopoietic stem cell transplantation. Clin
Transplant. 38(e15186)2024.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Elhaj Mahmoud D, Hérivaux A, Morio F,
Briard B, Vigneau C, Desoubeaux G, Bouchara JP, Gangneux JP, Nevez
G, Le Gal S and Papon N: The epidemiology of invasive fungal
infections in transplant recipients. Biomed J.
47(100719)2024.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Pana ZD, Roilides E, Warris A, Groll AH
and Zaoutis T: Epidemiology of invasive fungal disease in children.
J Pediatric Infect Dis Soc. 6 (Suppl 1):S3–S11. 2017.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Steinbach WJ and Fisher BT: International
collaborative on contemporary epidemiology and diagnosis of
invasive fungal disease in children. J Pediatric Infect Dis Soc. 6
(Suppl 1):S1–S2. 2017.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Czyżewski K, Gałązka P, Frączkiewicz J,
Salamonowicz M, Szmydki-Baran A, Zając-Spychała O,
Gryniewicz-Kwiatkowska O, Zalas-Więcek P, Chełmecka-Wiktorczyk L,
Irga-Jaworska N, et al: Epidemiology and outcome of invasive fungal
disease in children after hematopoietic cell transplantation or
treated for malignancy: Impact of national programme of antifungal
prophylaxis. Mycoses. 62:990–998. 2019.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Wu X, Ma X, Song T, Liu J, Sun Y and Wu D:
The indirect effects of CMV reactivation on patients following
allogeneic hematopoietic stem cell transplantation: An evidence
mapping. Ann Hematol. 103:917–933. 2024.PubMed/NCBI View Article : Google Scholar
|
|
47
|
van der Maas NG, von Asmuth EGJ, Berghuis
D, van Schouwenburg PA, Putter H, van der Burg M and Lankester AC:
Modeling influencing factors in B-cell reconstitution after
hematopoietic stem cell transplantation in children. Front Immunol.
12(684147)2021.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Marie-Cardine A, Divay F, Dutot I, Green
A, Perdrix A, Boyer O, Contentin N, Tilly H, Tron F, Vannier JP and
Jacquot S: Transitional B cells in humans: characterization and
insight from B lymphocyte reconstitution after hematopoietic stem
cell transplantation. Clin Immunol. 127:14–25. 2008.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Maliszewski CR, Sato TA, Vanden Bos T,
Waugh S, Dower SK, Slack J, Beckmann MP and Grabstein KH: Cytokine
receptors and B cell functions. I. Recombinant soluble receptors
specifically inhibit IL-1- and IL-4-induced B cell activities in
vitro. J Immunol. 144:3028–3033. 1990.PubMed/NCBI
|
|
50
|
Pan L, Sato S, Frederick JP, Sun XH and
Zhuang Y: Impaired immune responses and B-cell proliferation in
mice lacking the Id3 gene. Mol Cell Biol. 19:5969–5980.
1999.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Inaba A, Tuong ZK, Zhao TX, Stewart AP,
Mathews R, Truman L, Sriranjan R, Kennet J, Saeb-Parsy K, Wicker L,
et al: Low-dose IL-2 enhances the generation of IL-10-producing
immunoregulatory B cells. Nat Commun. 14(2071)2023.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Roy K, Chakraborty M, Kumar A, Manna AK
and Roy NS: The NFκB signaling system in the generation of B-cell
subsets: from germinal center B cells to memory B cells and plasma
cells. Front Immunol. 14(1185597)2023.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Puerta-Alcalde P and Garcia-Vidal C:
Changing epidemiology of invasive fungal disease in allogeneic
hematopoietic stem cell transplantation. J Fungi (Basel).
7(848)2021.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Lehrnbecher T, Schöning S, Poyer F, Georg
J, Becker A, Gordon K, Attarbaschi A and Groll AH: Incidence and
outcome of invasive fungal diseases in children with hematological
malignancies and/or allogeneic hematopoietic stem cell
transplantation: Results of a prospective multicenter study. Front
Microbiol. 10(681)2019.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Said AM, Afridi F, Redell MS, Vrana C,
O'Farrell C, Scheurer ME, Dailey Garnes NJ, Gramatges MM and Dutta
A: Invasive candidiasis in pediatric hematologic malignancy:
Increased risk of dissemination with Candida tropicalis.
Pediatr Infect Dis J. 44:58–63. 2025.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Barantsevich N and Barantsevich E:
Diagnosis and treatment of invasive candidiasis. Antibiotics
(Basel). 11(718)2022.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Wang L, Wang Y, Hu J, Sun Y, Huang H, Chen
J, Li J, Ma J, Li J, Liang Y, et al: Clinical risk score for
invasive fungal diseases in patients with hematological
malignancies undergoing chemotherapy: China assessment of
antifungal therapy in hematological diseases (CAESAR) study. Front
Med. 13:365–377. 2019.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Sun Y, Meng F, Han M, Zhang X, Yu L, Huang
H, Wu D, Ren H, Wang C, Shen Z, et al: Epidemiology, management,
and outcome of invasive fungal disease in patients undergoing
hematopoietic stem cell transplantation in China: A multicenter
prospective observational study. Biol Blood Marrow Transplant.
21:1117–1126. 2015.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Celkan T, Kizilocak H, Evim M, Meral Güneş
A, Özbek NY, Yarali N, Ünal E, Patiroğlu T, Yilmaz Karapinar D,
Sarper N, et al: Hepatosplenic fungal infections in children with
leukemia-risk factors and outcome: A multicentric study. J Pediatr
Hematol Oncol. 41:256–260. 2019.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Machado M, Fortún J and Muñoz P: Invasive
aspergillosis: A comprehensive review. Med Clin (Barc).
163:189–198. 2024.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Boyer J, Feys S, Zsifkovits I, Hoenigl M
and Egger M: Treatment of invasive aspergillosis: How it's going,
where it's heading. Mycopathologia. 188:667–681. 2023.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Duréault A, Tcherakian C, Poiree S,
Catherinot E, Danion F, Jouvion G, Bougnoux ME, Mahlaoui N, Givel
C, Castelle M, et al: Spectrum of pulmonary aspergillosis in
hyper-IgE syndrome with autosomal-dominant STAT3 deficiency. J
Allergy Clin Immunol Pract. 7:1986–1995.e3. 2019.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Luckowitsch M, Rudolph H, Bochennek K,
Porto L and Lehrnbecher T: Central nervous system mold infections
in children with hematological malignancies: Advances in diagnosis
and treatment. J Fungi (Basel). 7(168)2021.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Karaman S, Kebudi R, Kizilocak H, Karakas
Z, Demirag B, Evim MS, Yarali N, Kaya Z, Karagun BS, Aydogdu S, et
al: Central nervous system fungal infections in children with
leukemia and undergoing hematopoietic stem cell transplantation: A
retrospective multicenter study. J Pediatr Hematol Oncol.
44:e1039–e1045. 2022.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Alexander BD, Lamoth F, Heussel CP, Prokop
CS, Desai SR, Morrissey CO and Baddley JW: Guidance on imaging for
invasive pulmonary aspergillosis and mucormycosis: From the imaging
working group for the revision and update of the consensus
definitions of fungal disease from the EORTC/MSGERC. Clin Infect
Dis. 72 (Suppl 2):S79–S88. 2021.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Wu Y, Yan L, Wang H, et al: Clinical study
on empirical and diagnostic-driven (pre-emptive) therapy of
voriconazole in severe aplastic anaemia patients with invasive
fungal disease after intensive immunosuppressive therapy. Eur J
Clin Microbiol Infect Dis. 40:949–954. 2021.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Fang W, Wu J, Cheng M, Zhu X, Du M, Chen
C, Liao W, Zhi K and Pan W: Diagnosis of invasive fungal
infections: challenges and recent developments. J Biomed Sci.
30(42)2023.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Lamoth F, Cruciani M, Mengoli C,
Castagnola E, Lortholary O, Richardson M and Marchetti O: Third
European Conference on Infections in Leukemia (ECIL-3). β-Glucan
antigenemia assay for the diagnosis of invasive fungal infections
in patients with hematological malignancies: A systematic review
and meta-analysis of cohort studies from the third European
conference on infections in leukemia (ECIL-3). Clin Infect Dis.
54:633–643. 2012.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Chen M, Xu Y, Hong N, Yang Y, Lei W, Du L,
Zhao J, Lei X, Xiong L, Cai L, et al: Epidemiology of fungal
infections in China. Front Med. 12:58–75. 2018.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Çağlar İ, Özkerim D, Tahta N, Düzgöl M,
Bayram N, Demirağ B, Karapinar TH, Sorguç Y, Gözmen S, Dursun V, et
al: Assessment of serum galactomannan test results of pediatric
patients with hematologic malignancies according to consecutive
positivity and threshold level in terms of invasive aspergillosis
diagnosis: Cross-sectional research in a tertiary care hospital. J
Pediatr Hematol Oncol. 42:e271–e276. 2020.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Springer J, Held J, Mengoli C, Schlegel
PG, Gamon F, Träger J, Kurzai O, Einsele H, Loeffler J and Eyrich
M: Diagnostic performance of (1→3)-β-D-glucan alone and in
combination with Aspergillus PCR and galactomannan in serum
of pediatric patients after allogeneic hematopoietic stem cell
transplantation. J Fungi (Basel). 7(238)2021.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Ferreras-Antolin L, Borman A, Diederichs
A, Warris A and Lehrnbecher T: Serum beta-D-glucan in the diagnosis
of invasive fungal disease in neonates, children and adolescents: A
critical analysis of current data. J Fungi (Basel).
8(1262)2022.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Saffioti C, Mesini A, Bandettini R and
Castagnola E: Diagnosis of invasive fungal disease in children: A
narrative review. Expert Rev Anti Infect Ther. 17:895–909.
2019.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Warris A and Lehrnbecher T: Progress in
the diagnosis of invasive fungal disease in children. Curr Fungal
Infect Rep. 11:35–44. 2017.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Otto WR and Green AM: Fungal infections in
children with haematologic malignancies and stem cell transplant
recipients. Br J Haematol. 189:607–624. 2020.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Cao GJ, Xing ZF, Hua L, Ji YH, Sun JB and
Zhao Z: Evaluation of the diagnostic performance of panfungal
polymerase chain reaction assay in invasive fungal diseases. Exp
Ther Med. 14:4208–4214. 2017.PubMed/NCBI View Article : Google Scholar
|
|
77
|
White PL, Alanio A, Brown L, Cruciani M,
Hagen F, Gorton R, Lackner M, Millon L, Morton CO,
Rautemaa-Richardson R, et al: An overview of using fungal DNA for
the diagnosis of invasive mycoses. Expert Rev Mol Diagn.
22:169–184. 2022.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Singh S and Singh M, Verma N, Sharma M,
Pradhan P, Chauhan A, Jaiswal N, Chakrabarti A and Singh M:
Comparative accuracy of 1,3 beta-D glucan and galactomannan for
diagnosis of invasive fungal infections in pediatric patients: A
systematic review with meta-analysis. Med Mycol. 59:139–148.
2021.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Wang Z, Pan M and Zhu J: Global burden of
reported lower respiratory system fungal infection. Front Cell
Infect Microbiol. 15(1542922)2025.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Srivali N, Permpalung N, Ammannagari N,
Cheungpasitporn W and Bischof EF: Significance of halo, reversed
halo and air crescent signs in lymphomatoid granulomatosis and
pulmonary fungal infections. Thorax. 68:1070–1071. 2013.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Lamoth F, Prakash K, Beigelman-Aubry C and
Baddley JW: Lung and sinus fungal infection imaging in
immunocompromised patients. Clin Microbiol Infect. 30:296–305.
2024.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Alamdaran SA, Bagheri R, Darvari SF,
Bakhtiari E and Ghasemi A: Pulmonary invasive fungal disease:
Ultrasound and computed tomography scan findings. Thorac Res Pract.
24:292–297. 2023.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Perez P, Patiño J, Franco AA, Rosso F,
Beltran E, Manzi E, Castro A, Estacio M and Valencia DM:
Prophylaxis for invasive fungal infection in pediatric patients
with allogeneic hematopoietic stem cell transplantation. Blood Res.
57:34–40. 2022.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Elitzur S, Arad-Cohen N, Barg A,
Litichever N, Bielorai B, Elhasid R, Fischer S, Fruchtman Y, Gilad
G, Kapelushnik J, et al: Mucormycosis in children with
haematological malignancies is a salvageable disease: A report from
the israeli study group of childhood leukemia. Br J Haematol.
189:339–350. 2020.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Bonifaz A, Tirado-Sánchez A,
Hernández-Medel ML, Araiza J, Kassack JJ, Del Angel-Arenas T,
Moisés-Hernández JF, Paredes-Farrera F, Gómez-Apo E, Treviño-Rangel
RJ and González GM: Mucormycosis at a tertiary-care center in
Mexico. A 35-year retrospective study of 214 cases. Mycoses.
64:372–380. 2021.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Pagano L, Dragonetti G, De Carolis E,
Veltri G, Del Principe MI and Busca A: Developments in identifying
and managing mucormycosis in hematologic cancer patients. Expert
Rev Hematol. 13:895–905. 2020.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Antoniadi K, Iosifidis E, Vasileiou E,
Tsipou C, Lialias I, Papakonstantinou E, Kattamis A,
Polychronopoulou S, Roilides E and Tragiannidis A: Invasive
mucormycosis in children with malignancies: Report from the
infection working group of the hellenic society of pediatric
hematology-oncology. J Pediatr Hematol Oncol. 43:176–179.
2021.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Zhang Z, Bills GF and An Z: Advances in
the treatment of invasive fungal disease. PLoS Pathog.
19(e1011322)2023.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Sun Y, Hu J, Huang H, Chen J, Li J, Ma J,
Li J, Liang Y, Wang J, Li Y, et al: Clinical risk score for
predicting invasive fungal disease after allogeneic hematopoietic
stem cell transplantation: Analysis of the China assessment of
antifungal therapy in hematological diseases (CAESAR) study.
Transpl Infect Dis. 23(e13611)2021.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Zhang T, Shen Y and Feng S: Clinical
research advances of isavuconazole in the treatment of invasive
fungal diseases. Front Cell Infect Microbiol.
12(1049959)2022.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Herbrecht R, Denning DW, Patterson TF,
Bennett JE, Greene RE, Oestmann JW, Kern WV, Marr KA, Ribaud P,
Lortholary O, et al: Voriconazole versus amphotericin B for primary
therapy of invasive aspergillosis. N Engl J Med. 347:408–415.
2002.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Turkova A, Roilides E and Sharland M:
Amphotericin B in neonates: Deoxycholate or lipid formulation as
first-line therapy-is there a ‘right’ choice? Curr Opin Infect Dis.
24:163–171. 2011.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Tissot F, Agrawal S, Pagano L, Petrikkos
G, Groll AH, Skiada A, Lass-Flörl C, Calandra T, Viscoli C and
Herbrecht R: ECIL-6 guidelines for the treatment of invasive
candidiasis, aspergillosis and mucormycosis in leukemia and
hematopoietic stem cell transplant patients. Haematologica.
102:433–444. 2017.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Ruhnke M, Cornely OA, Schmidt-Hieber M,
Alakel N, Boell B, Buchheidt D, Christopeit M, Hasenkamp J, Heinz
WJ, Hentrich M, et al: Treatment of invasive fungal diseases in
cancer patients-Revised 2019 recommendations of the infectious
diseases working party (AGIHO) of the German society of hematology
and oncology (DGHO). Mycoses. 63:653–682. 2020.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Tu S, Zhang K, Wang N, Chu J, Yang L and
Xie Z: Comparative study of posaconazole and voriconazole for
primary antifungal prophylaxis in patients with pediatric acute
leukemia. Sci Rep. 13(18789)2023.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Lee KH, Lim YT, Hah JO, Kim YK, Lee CH and
Lee JM: Voriconazole plus caspofungin for treatment of invasive
fungal infection in children with acute leukemia. Blood Res.
52:167–173. 2017.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Qiu KY, Liao XY, Fang JP, Xu HG, Li Y,
Huang K and Zhou DH: Combination antifungal treatment for invasive
fungal disease after hematopoietic stem cell transplantation in
children with hematological disorders. Transpl Infect Dis.
21(e13066)2019.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Goscicki BK, Yan SQ, Mathew S, Mauguen A
and Cohen N: A retrospective analysis of micafungin prophylaxis in
children under 12 years undergoing chemotherapy or hematopoietic
stem cell transplantation. J Pediatr Pharmacol Ther. 29:379–384.
2024.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Kazakou N, Vyzantiadis TA, Gambeta A,
Vasileiou E, Tsotridou E, Kotsos D, Giantsidi A, Saranti A,
Palabougiouki M, Ioannidou M, et al: Invasive fungal infections in
a pediatric hematology-oncology department: A 16-year retrospective
study. Curr Med Mycol. 6:37–42. 2020.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Itsaradisaikul S, Pakakasama S,
Boonsathorn S, Techasaensiri C, Rattanasiri S and Apiwattanakul N:
Invasive fungal disease among pediatric and adolescent patients
undergoing itraconazole prophylaxis after hematopoietic stem cell
transplantation. Transplant Proc. 53:2021–2028. 2021.PubMed/NCBI View Article : Google Scholar
|
|
101
|
McCann S, Sinha J, Wilson WS, McKinzie CJ,
Garner LM and Gonzalez D: Population pharmacokinetics of
posaconazole in immune-compromised children and assessment of
target attainment in invasive fungal disease. Clin Pharmacokinet.
62:997–1009. 2023.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Delarze E and Sanglard D: Defining the
frontiers between antifungal resistance, tolerance and the concept
of persistence. Drug Resist Updat. 23:12–19. 2015.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Kadariswantiningsih IN, Empitu MA, Santosa
TI and Alimu Y: Antifungal resistance: Emerging mechanisms and
implications (Review). Mol Med Rep. 32(247)2025.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Berman J and Krysan DJ: Drug resistance
and tolerance in fungi. Nat Rev Microbiol. 18:319–331.
2020.PubMed/NCBI View Article : Google Scholar
|
|
105
|
Okada A, Kariya M, Irie K, Okada Y,
Hiramoto N, Hashimoto H, Kajioka R, Maruyama C, Kasai H, Hamori M,
et al: Population pharmacokinetics of vancomycin in patients
undergoing allogeneic hematopoietic stem-cell transplantation. J
Clin Pharmacol. 58:1140–1149. 2018.PubMed/NCBI View Article : Google Scholar
|
|
106
|
Fisher BT, Zaoutis T, Dvorak CC, Nieder M,
Zerr D, Wingard JR, Callahan C, Villaluna D, Chen L, Dang H, et al:
Effect of caspofungin vs fluconazole prophylaxis on invasive fungal
disease among children and young adults with acute myeloid
leukemia: A randomized clinical trial. JAMA. 322:1673–1681.
2019.PubMed/NCBI View Article : Google Scholar
|
|
107
|
Boeriu E, Borda A, Vulcanescu DD, Sarbu V,
Arghirescu ST, Ciorica O, Bratosin F, Marincu I and Horhat FG:
Diagnosis and management of febrile neutropenia in pediatric
oncology patients-a systematic review. Diagnostics (Basel).
12(1800)2022.PubMed/NCBI View Article : Google Scholar
|
|
108
|
Fisher BT: Fungal diagnostic testing and
therapy: Navigating the neutropenic period in children with
high-risk leukemia. Hematology Am Soc Hematol Educ Program.
2021:361–367. 2021.PubMed/NCBI View Article : Google Scholar
|
|
109
|
Villarroel M, Avilés CL, Silva P, Guzmán
AM, Poggi H, Alvarez AM, Becker A, O'ryan M, Salgado C, Topelberg
S, et al: Risk factors associated with invasive fungal disease in
children with cancer and febrile neutropenia: A prospective
multicenter evaluation. Pediatr Infect Dis J. 29:816–821.
2010.PubMed/NCBI View Article : Google Scholar
|
|
110
|
Wang J, Liang J, He M, Xie Q, Wu Q, Shen
G, Zhu B, Yu J, Yu L, Tan X, et al: Chinese expert consensus on
intestinal microecology and management of digestive tract
complications related to tumor treatment (version 2022). J Cancer
Res Ther. 18:1835–1844. 2022.PubMed/NCBI View Article : Google Scholar
|
|
111
|
Wang Q, He M, Liang J, Tan X, Wu Q, Wang
J, Li X, Qiao M, Huang Z, Xie Q, et al: Chinese guidelines for
integrated diagnosis and treatment of intestinal microecology
technologies in tumor application (2024 edition). J Cancer Res
Ther. 20:1130–1140. 2024.PubMed/NCBI View Article : Google Scholar
|
|
112
|
Ferreras-Antolín L, Sharland M and Warris
A: Management of invasive fungal disease in neonates and children.
Pediatr Infect Dis J. 38 (6S Suppl 1):S2–S6. 2019.PubMed/NCBI View Article : Google Scholar
|
|
113
|
Bochennek K, Simon A, Laws HJ, Groll AH
and Lehrnbecher T: Febrile neutropenia in pediatric and adolescent
cancer patients. Monatsschr Kinderheilkd. 169:443–450.
2021.PubMed/NCBI View Article : Google Scholar : (In German).
|
|
114
|
Ko BS, Chen WT, Kung HC, Wu UI, Tang JL,
Yao M, Chen YC, Tien HF, Chang SC, Chuang YC, et al: 2016 Guideline
strategies for the use of antifungal agents in patients with
hematological malignancies or hematopoietic stem cell
transplantation recipients in Taiwan. J Microbiol Immunol Infect.
51:287–301. 2018.PubMed/NCBI View Article : Google Scholar
|
|
115
|
Hon KLE, Chan VP, Leung AK, Leung KKY and
Hui WF: Invasive fungal infections in critically ill children:
Epidemiology, risk factors and antifungal drugs. Drugs Context.
13(2023-9-2)2024.PubMed/NCBI View Article : Google Scholar
|
|
116
|
Goldman JL and Abdel-Rahman SM:
Pharmacokinetic considerations in treating invasive pediatric
fungal infections. Expert Opin Drug Metab Toxicol. 12:645–655.
2016.PubMed/NCBI View Article : Google Scholar
|
|
117
|
Maertens J, Pagano L, Azoulay E and Warris
A: Liposomal amphotericin B-the present. J Antimicrob Chemother. 77
(Suppl 2):ii11–ii20. 2022.PubMed/NCBI View Article : Google Scholar
|
|
118
|
Härtel C, Scholz T, Kuhn M, Bendiks M,
Göpel W, Lauten M and Herting E: Innate immune responses to
Stenotrophomonas maltophilia in immunocompromised pediatric
patients and the effect of taurolidine. J Microbiol Immunol Infect.
46:115–120. 2013.PubMed/NCBI View Article : Google Scholar
|
|
119
|
Ruijters VJ, Oosterom N, Wolfs TFW, van
den Heuvel-Eibrink MM and van Grotel M: Frequency and determinants
of invasive fungal infections in children with solid and
hematologic malignancies in a nonallogeneic stem cell
transplantation setting: A narrative review. J Pediatr Hematol
Oncol. 41:345–354. 2019.PubMed/NCBI View Article : Google Scholar
|
|
120
|
Giannella M, Lanternier F, Dellière S,
Groll AH, Mueller NJ, Alastruey-Izquierdo A and Slavin MA: ECCMID
study groups on Invasive Fungal Infection and Infection in
Immunocompromised Hosts. Invasive fungal disease in the
immunocompromised host: changing epidemiology, new antifungal
therapies, and management challenges. Clin Microbiol Infect.
31:29–36. 2025.PubMed/NCBI View Article : Google Scholar
|
|
121
|
Jia M, Zhang Q, Qin Z, Wang D, Liu P, Yang
J and Zhang X: Dose optimisation of posaconazole and therapeutic
drug monitoring in pediatric patients. Front Pharmacol.
13(833303)2022.PubMed/NCBI View Article : Google Scholar
|
|
122
|
Raad II, Zakhem AE, Helou GE, Jiang Y,
Kontoyiannis DP and Hachem R: Clinical experience of the use of
voriconazole, caspofungin or the combination in primary and salvage
therapy of invasive aspergillosis in haematological malignancies.
Int J Antimicrob Agents. 45:283–288. 2015.PubMed/NCBI View Article : Google Scholar
|
|
123
|
John J, Loo A, Mazur S and Walsh TJ:
Therapeutic drug monitoring of systemic antifungal agents: A
pragmatic approach for adult and pediatric patients. Expert Opin
Drug Metab Toxicol. 15:881–895. 2019.PubMed/NCBI View Article : Google Scholar
|
|
124
|
Kanaujia R, Biswal M, Angrup A and Ray P:
Diagnostic accuracy of the metagenomic next-generation sequencing
(mNGS) for detection of bacterial meningoencephalitis: A systematic
review and meta-analysis. Eur J Clin Microbiol Infect Dis.
41:881–891. 2022.PubMed/NCBI View Article : Google Scholar
|
|
125
|
Gutiérrez-García L, Esteban-Cantos A,
Rodríguez-Centeno J, Marcelo-Calvo C, Arribas JR and Rodés B:
Duplex digital PCR assay on microfluidic chamber arrays for total
HIV DNA reservoir quantification in persons with HIV. Sci Rep.
15(31658)2025.PubMed/NCBI View Article : Google Scholar
|
|
126
|
Fan C, He N and Yuan J: Cascaded
amplifying circuit enables sensitive detection of fungal pathogens.
Biosens Bioelectron. 250(116058)2024.PubMed/NCBI View Article : Google Scholar
|
|
127
|
Hoenigl M, Salmanton-García J, Walsh TJ,
Nucci M, Neoh CF, Jenks JD, Lackner M, Sprute R, Al-Hatmi AMS,
Bassetti M, et al: Global guideline for the diagnosis and
management of rare mould infections: An initiative of the European
confederation of medical mycology in cooperation with the
international society for human and animal mycology and the
American society for microbiology. Lancet Infect Dis. 21:e246–e257.
2021.PubMed/NCBI View Article : Google Scholar
|
|
128
|
Sonego B, Corio A, Mazzoletti V, Zerbato
V, Benini A, di Meo N, Zalaudek I, Stinco G, Errichetti E and Zelin
E: Trichophyton indotineae, an emerging drug-resistant
dermatophyte: A review of the treatment options. J Clin Med.
13(3558)2024.PubMed/NCBI View Article : Google Scholar
|
|
129
|
Ashkenazi-Hoffnung L, Bilavsky E, Levy I,
Grisaru G, Sadot E, Ben-Ami R, Novikov A, Fischer S, Nahum E and
Scheuerman O: Isavuconazole as successful salvage therapy for
mucormycosis in pediatric patients. Pediatr Infect Dis J.
39:718–724. 2020.PubMed/NCBI View Article : Google Scholar
|
|
130
|
Fernández Ledesma B, Mendoza-Palomar N,
Melendo Pérez S, Fernández-Polo A, Renedo Miró B, Pau Parra A,
Luque Pardos S, Grau Cerrato S, Vima Bofarull J, Martín-Gómez MT,
et al: Isavuconazole use and TDM in real-world pediatric practice.
Antimicrob Agents Chemother. 67(e0082923)2023.PubMed/NCBI View Article : Google Scholar
|
|
131
|
Eissa S, Khedr R, Romeih M, Halaby L,
Elanany M and Madney Y: Clinical characteristics and outcome of
invasive fungal sinusitis in children with hematological
malignancies. Med Mycol. 60(myac010)2022.PubMed/NCBI View Article : Google Scholar
|
|
132
|
Egan G, Robinson PD, Martinez JPD,
Alexander S, Ammann RA, Dupuis LL, Fisher BT, Lehrnbecher T,
Phillips B, Cabral S, et al: Efficacy of antibiotic prophylaxis in
patients with cancer and hematopoietic stem cell transplantation
recipients: A systematic review of randomized trials. Cancer Med.
8:4536–4546. 2019.PubMed/NCBI View Article : Google Scholar
|
|
133
|
Bossù G, Di Sario R, Muratore E, Leardini
D, Pession A, Esposito S and Masetti R: Novel insights into fungal
infections prophylaxis and treatment in pediatric patients with
cancer. Antibiotics (Basel). 11(1316)2022.PubMed/NCBI View Article : Google Scholar
|
|
134
|
Chen SC, Perfect J, Colombo AL, Cornely
OA, Groll AH, Seidel D, Albus K, de Almedia JN Jr, Garcia-Effron G,
Gilroy N, et al: Global guideline for the diagnosis and management
of rare yeast infections: An initiative of the ECMM in cooperation
with ISHAM and ASM. Lancet Infect Dis. 21:e375–e386.
2021.PubMed/NCBI View Article : Google Scholar
|
|
135
|
Marty FM, Cornely OA, Mullane KM,
Ostrosky-Zeichner L, Maher RM, Croos-Dabrera R, Lu Q, Lademacher C,
Oren I, Schmitt-Hoffmann AH, et al: Isavuconazole for treatment of
invasive fungal diseases caused by more than one fungal species.
Mycoses. 61:485–497. 2018.PubMed/NCBI View Article : Google Scholar
|
|
136
|
Thompson GR, Huang H, Feng S, Yu Y,
Soriano A, Cornely OA, Kullberg BJ, Pappas PG, Kollef M, Vazquez
JA, et al: Rezafungin versus caspofungin for the treatment of
candidemia and invasive candidiasis: results from the double-blind,
randomized, phase 3 ReSTORE trial including the China extension
study. Open Forum Infect Dis. 12(ofaf555)2025.PubMed/NCBI View Article : Google Scholar
|
